Cher ML - Search Results

1

Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy.

Cher ML, Bianco FJ Jr, Lam JS, Davis LP, Grignon DJ, Sakr WA, Banerjee M, Pontes JE, Wood DP Jr. Cher ML, et al. J Urol. 1998 Oct;160(4):1387-91. J Urol. 1998. PMID: 9751361

2

Screening for prostate cancer.

Cher ML, Carroll PR. Cher ML, et al. West J Med. 1995 Mar;162(3):235-42. West J Med. 1995. PMID: 7536993 Free PMC article. Review.

3

High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.

Cher ML, Shinohara K, Breslin S, Vapnek J, Carroll PR. Cher ML, et al. Br J Urol. 1995 Jun;75(6):771-7. doi: 10.1111/j.1464-410x.1995.tb07389.x. Br J Urol. 1995. PMID: 7542137 Clinical Trial.

4

The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy.

Wolf JS Jr, Cher M, Dall'era M, Presti JC Jr, Hricak H, Carroll PR. Wolf JS Jr, et al. J Urol. 1995 Mar;153(3 Pt 2):993-9. J Urol. 1995. PMID: 7853590 Review.

5

Cellular proliferative fraction of metastatic lymph nodes predicts survival in stage D1 (TxN+M0) prostate cancer.

Cher ML, Stephenson RA, James BC, Carroll PR. Cher ML, et al. J Urol. 1996 May;155(5):1674-7. J Urol. 1996. PMID: 8627851

6

Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy.

Connolly JA, Presti JC Jr, Cher ML, Chew K, Shinohara K, Carroll PR. Connolly JA, et al. Among authors: cher ml. J Urol. 1997 Aug;158(2):515-8. J Urol. 1997. PMID: 9224336

7

Cher ML, Lewis PE, Banerjee M, Hurley PM, Sakr W, Grignon DJ, Powell IJ. Cher ML, et al. Clin Cancer Res. 1998 May;4(5):1273-8. Clin Cancer Res. 1998. PMID: 9607587

8

Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer.

Gheiler EL, Tefilli MV, Tiguert R, Grignon D, Cher ML, Sakr W, Pontes JE, Wood DP Jr. Gheiler EL, et al. Among authors: cher ml. Urology. 1998 May;51(5):789-95. doi: 10.1016/s0090-4295(98)00096-x. Urology. 1998. PMID: 9610593

9

Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.

Triest JA, Grignon DJ, Cher ML, Kocheril SV, Montecillo EJ, Talati B, Tekyi-Mensah S, Pontes JE, Hillman GG. Triest JA, et al. Among authors: cher ml. Clin Cancer Res. 1998 Aug;4(8):2009-14. Clin Cancer Res. 1998. PMID: 9717832

10

Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.

Wood DP Jr, Beaman A, Banerjee M, Powell I, Pontes E, Cher ML. Wood DP Jr, et al. Among authors: cher ml. Clin Cancer Res. 1998 Sep;4(9):2119-23. Clin Cancer Res. 1998. PMID: 9748128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters